Showing results (61-70 of 76) with videos related to
Sort By:
Pageof 8
Journal of Clinical Gastroenterology|September 15, 2010
A multidisciplinary therapeutic approach for reducing the risk of psychiatric side effects in patients with chronic hepatitis C treated with pegylated interferon α and ribavirinSergio Neri, Gaetano Bertino, Antonio Petralia, et al.Journal of Gastrointestinal Cancer|February 11, 2014
Rare benign tumors of the liver: still rare?Gaetano Bertino, Annalisa Ardiri, Shirin Demma, et al.World Journal of Hepatology|May 12, 2016
Hepatocellular carcinoma and the risk of occupational exposureVenerando Rapisarda, Carla Loreto, Michele Malaguarnera, et al.Plos One|October 24, 2014
Individualized treatment of genotype 1 naïve patients: an Italian multicenter field practice experienceAlessandra Mangia, Giovanni Cenderello, Alessandra Orlandini, et al.International Journal of Molecular Sciences|February 24, 2024
Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular CarcinomaLydia Giannitrapani, Francesca Di Gaudio, Melchiorre Cervello, et al.Journal of Viral Hepatitis|April 25, 2021
Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST-HCV cohortVincenza Calvaruso, Salvatore Petta, Irene Cacciola, et al.Scandinavian Journal of Gastroenterology|October 1, 2019
Rate of non-response to ursodeoxycholic acid in a large real-world cohort of primary biliary cholangitis patients in ItalyUmberto Vespasiani-Gentilucci, Floriano Rosina, Valeria Pace-Palitti, et al.Drugs in Context|January 7, 2021
Sustained virological response in patients with HCV treated with daclatasvir plus sofosbuvir, with or without ribavirin: a large, field-practice studyRodolfo Sacco, Vincenzo Messina, Umberto Vespasiani Gentilucci, et al.The American Journal of Gastroenterology|May 29, 2019
Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? The REAL ExperienceVincenza Calvaruso, Irene Cacciola, Anna Licata, et al.Gastroenterology|April 16, 2018
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral AgentsVincenza Calvaruso, Giuseppe Cabibbo, Irene Cacciola, et al.Pageof 8